Gland Pharma Limited
Gland Pharma Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: GLAND and BSE: 543245 (ISIN INE068V01023).
It has a market capitalisation of ₹49,754 crore, a last close of ₹3,020 on 2026-10-19, a one-year return of 55.8%.
Valuation: a price-to-earnings ratio of 44.08x, a price-to-book ratio of 4.80x, a dividend yield of 0.7%.
Profitability: return on equity of 10.5%, return on capital employed of 14.6%, an operating margin of 26.0%.
Growth: sales growth of 21.1% a year over three years, net profit growth of 9.6% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.02x, promoter holding of 45.8%.
| Metric | Value |
|---|---|
| Market capitalisation | 49,754 |
| Last close | ₹3,020 |
| P/E (TTM) | 44.08x |
| P/B | 4.80x |
| Dividend yield | 0.7% |
| ROE (FY) | 10.5% |
| ROCE (FY) | 14.6% |
| Operating margin (TTM) | 26.0% |
| Sales growth, 3-year CAGR | 21.1% |
| Profit growth, 3-year CAGR | 9.6% |
| Debt / equity | 0.02x |
| Promoter holding | 45.8% |
| 1-year return | 55.8% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means